Structure Function Analysis of Integrins alpha1beta1 and alpha2beta2
Structure Function Analysis of Integrins alpha1beta1 and alpha2beta2
批准号:
8002171
负责人:
CHARLES R SANDERS
金额:
$38.75万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-07-01 至 2014-06-30
关键词:
3-DimensionalAffinityAmino AcidsAreaBindingBiophysicsCell DeathCell physiologyCellsCellular biologyChronic Kidney FailureCollagenCollagen ReceptorsCollagen Type IVComplexCytoplasmic StructuresCytoplasmic TailDiseaseECM receptorEtiologyExtracellular DomainExtracellular MatrixGoalsHealthHomeostasisIndividualInduced MutationIntegrin alpha1Integrin beta3IntegrinsKidney GlomerulusKnowledgeLengthLigand BindingLigandsMammalian CellMediatingMesenchymalMethodsModelingMolecularMolecular BiologyMutagenesisNephronsParentsPathologyPlayProteinsPublishingRelative (related person)Renal glomerular diseaseResolutionRoleScanningSignal TransductionSpecificityStructureStructure-Activity RelationshipTestingTransmembrane DomainUnited StatesWorkbasecell typefollow-upglomerulosclerosisinsightintegrin alpha1beta1intermolecular interactionmembrane modelmesangial cellmutantnovelpublic health relevancereceptorreceptor bindingrole model
中文摘要
描述(由申请人提供):整合素是由非共价结合的α和β亚基形成的跨膜受体。β -1亚基结合12个α亚基,表明α - β -1整合素的功能特异性是由α亚基决定的。这在两种主要的胶原结合受体,整合素α -1- β -1和α -2- β -1中可见,它们不仅对各种胶原具有不同的亲和力(由它们的细胞外结构域决定),而且还以一种严重依赖于它们的跨膜(TM)和细胞质(CT)结构域的方式介导不同的信号。含有整合素的β -1的TM和CT结构域转导信号的分子机制尚不清楚,因为大多数发表的关于这些结构域的研究都是用高度可调节的α -s- β -3整合素进行的,主要集中在β -3亚基本身。我们最近发现,整合素α -1和α -2 TM和CT结构域对整合素α -1- β -1和α -2- β -1功能的特异性有很大的影响。此外,已经确定了通过整合素α -1和α -2 CT尾部调节特定信号传导的关键氨基酸。因此,本项目的总体目标是确定整合素α -1- β -1和α -2- β -1的TM和CT结构域有助于其功能特异性的机制。特别是,我们将验证整合素α -1- β -1和α -2- β -1的TM或CT结构域内的特定残基对于赋予结构和功能特异性至关重要的假设。为了验证这一假设,我们将:目标1)确定单个积分α -1、α -2和β -1 TM/CT结构域以及α -1- β -1和α -2- β -1 TM/CT异源二聚体的结构。目的2)确定控制整合素α -1- β -1和α -2- β -1的α -1和α -2 TM结构域在细胞功能中的特异性和功能的关键氨基酸。目的3)建立TM/CD结构域在整合素α -1- β -1和α -2- β -1功能和特异性中的作用模型。
英文摘要
DESCRIPTION (provided by applicant): Integrins are transmembrane receptors formed by non-covalently bound alpha and beta subunits. The beta-1 subunit binds 12 alpha subunits, suggesting that specificity of function of alpha-beta-1 integrins are determined by the alpha subunits. This is seen in the two major collagen binding receptors, integrins alpha-1-beta-1 and alpha-2-beta-1, which not only have different affinities for various collagens (determined by their extracellular domains), but also mediate different signals in a manner that is critically dependent on their transmembrane (TM) and cytoplasmic (CT) domains. The molecular mechanisms whereby the TM and CT domains of beta-1 containing integrins transduce signals are poorly understood, as most published work on these domains was performed with the highly modulatable alpha-s-beta-3 integrins and focused primarily on the beta-3 subunit itself. We recently showed that integrin alpha-1 and alpha-2 TM and CT domains contribute to the very different specificities of integrin alpha-1-beta-1 and alpha-2-beta-1 function. Moreover, key amino acids that regulate specific signaling by the integrin alpha-1 and alpha-2 CT tails have been identified. Thus, the overall goal of this project is to identify the mechanisms whereby the TM and CT domains of integrins alpha-1-beta-1 and alpha-2-beta-1 contribute to their functional specificity. In particular, we will test the hypothesis that specific residues within the TM or CT domains of integrins alpha-1-beta-1 and alpha-2-beta-1 are critical for conferring structural and functional specificity. To test this hypothesis we will: Aim 1) Determine the structures of the individual integral alpha-1, alpha-2, and beta-1 TM/CT domains and of the alpha-1-beta-1 and alpha-2-beta-1 TM/CT heterodimers. Aim 2) Determine the critical amino acids that govern the specificity and functionality of the alpha-1 and alpha-2 TM domains of integrins alpha-1-beta-1 and alpha-2-beta-1 in cell function. Aim 3) Develop models for the roles of the TM/CD domains in integrin alpha-1-beta-1 and alpha-2-beta-1 function and specificity.
PUBLIC HEALTH RELEVANCE: We anticipate that this study will generate novel insights into the structural basis whereby the TM and CT domains of integrins alpha-1-beta-1 and alpha-2-beta-1 function. This knowledge is fundamental to our understanding of how integrins transduce signals from collagens within the glomerulus in both health and disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Targeting the PMP22 Protein to Develop Leads Against Charcot-Marie-Tooth Disease
-
批准号:10331038
-
项目类别:
-
资助金额:$19.81万
-
财政年份:2021
-
负责人:CHARLES R SANDERS
-
依托单位:
Cholesterol and the Amyloid Precursor Protein
-
批准号:8529109
-
项目类别:
-
资助金额:$29.64万
-
财政年份:2013
-
负责人:CHARLES R SANDERS
-
依托单位:
Cholesterol and the Amyloid Precursor Protein
-
批准号:8839797
-
项目类别:
-
资助金额:$29.83万
-
财政年份:2013
-
负责人:CHARLES R SANDERS
-
依托单位:
Cholesterol and the Amyloid Precursor Protein
-
批准号:8642200
-
项目类别:
-
资助金额:$29.64万
-
财政年份:2013
-
负责人:CHARLES R SANDERS
-
依托单位:
Structure Function Analysis of Integrins alpha1beta1 and alpha2beta2
-
批准号:9270816
-
项目类别:
-
资助金额:$0.1万
-
财政年份:2010
-
负责人:CHARLES R SANDERS
-
依托单位:
Structure Function Analysis of Integrins alpha1beta1 and alpha2beta2
-
批准号:8500247
-
项目类别:
-
资助金额:$30.83万
-
财政年份:2010
-
负责人:CHARLES R SANDERS
-
依托单位:
FASEB Summer Research Conference on Molecular Biophysics of Cellular Membranes
-
批准号:8004602
-
项目类别:
-
资助金额:$1.0万
-
财政年份:2010
-
负责人:CHARLES R SANDERS
-
依托单位:
Structure Function Analysis of Integrins alpha1beta1 and alpha2beta2
-
批准号:8286378
-
项目类别:
-
资助金额:$32.05万
-
财政年份:2010
-
负责人:CHARLES R SANDERS
-
依托单位:
Project 3
-
批准号:8151962
-
项目类别:
-
资助金额:$46.91万
-
财政年份:2010
-
负责人:CHARLES R SANDERS
-
依托单位:
Structure Function Analysis of Integrins alpha1beta1 and alpha2beta2
-
批准号:8097972
-
项目类别:
-
资助金额:$32.05万
-
财政年份:2010
-
负责人:CHARLES R SANDERS
-
依托单位:
Console upgrades for biological NMR spectrometers
-
批准号:7596116
-
项目类别:
-
资助金额:$45.99万
-
财政年份:2009
-
负责人:CHARLES R SANDERS
-
依托单位:
Project 4/FAD Mutations in the Amyloid Precursor Protein
-
批准号:7449169
-
项目类别:
-
资助金额:$15.89万
-
财政年份:2008
-
负责人:CHARLES R SANDERS
-
依托单位:
Overcoming the Barriers to Structural Analysis of GPCRs
-
批准号:7495988
-
项目类别:
-
资助金额:$32.0万
-
财政年份:2007
-
负责人:CHARLES R SANDERS
-
依托单位:
Overcoming the Barriers to Structural Analysis of GPCRs
-
批准号:7314257
-
项目类别:
-
资助金额:$32.62万
-
财政年份:2007
-
负责人:CHARLES R SANDERS
-
依托单位:
Overcoming the Barriers to Structural Analysis of GPCRs
-
批准号:7658743
-
项目类别:
-
资助金额:$32.0万
-
财政年份:2007
-
负责人:CHARLES R SANDERS
-
依托单位:
FAD Mutations in the Amyloid Precursor Protein
-
批准号:7098664
-
项目类别:
-
资助金额:$15.67万
-
财政年份:2006
-
负责人:CHARLES R SANDERS
-
依托单位:
FAD Mutations in the Amyloid Precursor Protein
-
批准号:7230245
-
项目类别:
-
资助金额:$18.32万
-
财政年份:2006
-
负责人:CHARLES R SANDERS
-
依托单位:
KCNE1 Structure and Interaction with KCNQ1 Channel
-
批准号:7032787
-
项目类别:
-
资助金额:$32.39万
-
财政年份:2005
-
负责人:CHARLES R SANDERS
-
依托单位:
Structural Basis for KCNE Modulation of the KCNQ1 Channel
-
批准号:7888065
-
项目类别:
-
资助金额:$32.94万
-
财政年份:2005
-
负责人:CHARLES R SANDERS
-
依托单位:
Structural Basis for KCNE Modulation of the KCNQ1 Channel
-
批准号:8446246
-
项目类别:
-
资助金额:$34.43万
-
财政年份:2005
-
负责人:CHARLES R SANDERS
-
依托单位:
海外基金